source
- AIDS activists criticize Biden-Gilead R&D settlement over HIV prevention patentsA group of AIDS activists have secured an R&D agreement that sits at the core of a settlement between the U.S. government and Gilead Sciences concerning patents on HIV prevention drugs. The activi…
- FDA issues final guidance for psychedelic drug developers and announces public hearingThe FDA has completed a set of clinical guidance documents aimed at companies developing psychedelic medicines. The guidance outlines expectations for trial design, safety monitoring, and data col…